指南与共识免疫规划卫生政策与健康促进

疟疾疫苗:世界卫生组织立场文件,2016年1月——建议

Malaria vaccine: WHO position paper, January 2016 - Recommendations.
指南 / 共识 · Vaccine · 2017-04-03

本文摘录世界卫生组织(WHO)2016年1月《疫情周报》疟疾疫苗立场文件中的建议,是WHO首份疟疾疫苗接种立场文件,聚焦唯一获得欧洲药品管理局(EMA)积极监管评估的疟疾疫苗,评估其公共卫生效益,并反映免疫战略咨询专家组(SAGE)与疟疾政策咨询委员会(MPAC)的联合建议。

要点

  • WHO首份疟疾疫苗立场文件,聚焦唯一获EMA积极监管评估的疟疾疫苗。
  • 建议为SAGE与MPAC联合建议,2015年10月SAGE会议讨论。
  • 立场文件评估疾病流行病学特征及疫苗公共卫生效益潜力。

核心结论

  • WHO发布首份疟疾疫苗立场文件,提出SAGE与MPAC联合建议。

研究设计与样本

  • WHO立场文件,基于证据评估并附证据质量分级表及证据到建议表。

主要发现

  • 聚焦唯一获EMA积极监管评估的疟疾疫苗,评估其公共卫生效益潜力。

临床怎么用

  • 立场文件主要关注疫苗在大规模免疫规划中的使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article presents the World Health Organization's (WHO) recommendations on the use of malaria vaccine excerpted from the WHO position paper on malaria vaccine published in the Weekly epidemiological Record in January 2016 [1]. The current document is the first WHO position paper on malaria vaccination and focuses primarily on the available evidence concerning the only malaria vaccine having received a positive regulation assessment from the European Medicines Agency (EMA) [2]. The position paper gives consideration to the epidemiological features of the disease and assesses the potential use of the vaccine for public health benefits. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence to recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the joint recommendation of the WHO's Strategic Advisory Group of Experts (SAGE) on immunization and the Malaria Policy Advisory Committee (MPAC). These recommendations were discussed by SAGE and MPAC at the October 2015 SAGE meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Malaria vaccine: WHO position paper, January 2016 - Recommendations. Vaccine. 2017. PMID: 28385607. doi:10.1016/j.vaccine.2016.10.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。